Product NDC: | 42747-726 |
Proprietary Name: | Sancuso |
Non Proprietary Name: | granisetron |
Active Ingredient(s): | 3.1 mg/24h & nbsp; granisetron |
Administration Route(s): | TRANSDERMAL |
Dosage Form(s): | PATCH |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 42747-726 |
Labeler Name: | ProStrakan, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA022198 |
Marketing Category: | NDA |
Start Marketing Date: | 20080912 |
Package NDC: | 42747-726-01 |
Package Description: | 1 POUCH in 1 CARTON (42747-726-01) > 1 PATCH in 1 POUCH > 168 h in 1 PATCH |
NDC Code | 42747-726-01 |
Proprietary Name | Sancuso |
Package Description | 1 POUCH in 1 CARTON (42747-726-01) > 1 PATCH in 1 POUCH > 168 h in 1 PATCH |
Product NDC | 42747-726 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | granisetron |
Dosage Form Name | PATCH |
Route Name | TRANSDERMAL |
Start Marketing Date | 20080912 |
Marketing Category Name | NDA |
Labeler Name | ProStrakan, Inc. |
Substance Name | GRANISETRON |
Strength Number | 3.1 |
Strength Unit | mg/24h |
Pharmaceutical Classes | Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC] |